Clinical Trial

Clinical Efficacy of Darqeen Capsule for the Management of Hypothyroidism Associated with Female Reproductive Hormonal Imbalance

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2025 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
STUDY OBJECTIVES 1. To assess the safety of Darqeen capsule for the management of Hypothyroidism 2. Evaluate the efficacy of Darqeen capsule for the management of Hypothyroidism 3. To provide an alternative cost-effective treatment for the management of females suffering from hypothyroidism. NULL HYPOTHESIS (HO) The Unani Medicine Darqeen capsule is not effective for the management of Hypothyroidism. ALTERNATE HYPOTHESIS (H1) Unani medicine Darqeen capsule is effective for the management of Hypothyroidism.
Trial Details
NCT Number NCT06826248
Lead Sponsor Hamdard University
Conditions Hypothyroidism
Enrollment 50 participants
Start Date 2024-07-02
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-13